NCT01433263
- Conditions
- Adenocarcinoma, Body Weight, Body Weight Changes, +26 more
- Locations
-
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site Tampa, Florida, United States
- Novartis Investigative Site Chicago, Illinois, United States
- Novartis Investigative Site Boston, Massachusetts, United States